Aurobindo Pharma has received an
approval to acquire 25% equity stake in Silicon Life Sciences (Silicon), a
company engaged in manufacture of non-sterile penems, from the existing
shareholder – ABS Mercantiles. Post this acquisition, the equity holding of the
company would increase to 100%, thereby making Silicon a wholly owned
subsidiary of the company. Friday, September 13, 2013
Epic Update : Aurobindo Pharma
Aurobindo Pharma has received an
approval to acquire 25% equity stake in Silicon Life Sciences (Silicon), a
company engaged in manufacture of non-sterile penems, from the existing
shareholder – ABS Mercantiles. Post this acquisition, the equity holding of the
company would increase to 100%, thereby making Silicon a wholly owned
subsidiary of the company. 
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment